J C Monge

889 total citations
17 papers, 751 citations indexed

About

J C Monge is a scholar working on Molecular Biology, Physiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, J C Monge has authored 17 papers receiving a total of 751 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Physiology and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in J C Monge's work include Nitric Oxide and Endothelin Effects (4 papers), Drug Transport and Resistance Mechanisms (2 papers) and Liver Disease Diagnosis and Treatment (2 papers). J C Monge is often cited by papers focused on Nitric Oxide and Endothelin Effects (4 papers), Drug Transport and Resistance Mechanisms (2 papers) and Liver Disease Diagnosis and Treatment (2 papers). J C Monge collaborates with scholars based in Canada, United States and Argentina. J C Monge's co-authors include Duncan J. Stewart, Allan D. Sniderman, Farida Mohamed, Krystyna Teichert-Kuliszewska, Michelle P. Bendeck, Saeid Babaei, S W Law, Bang H. Hoang, Rita Kohen Avramoglu and Katherine Cianflone and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Journal of the American College of Cardiology.

In The Last Decade

J C Monge

17 papers receiving 725 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J C Monge Canada 13 261 219 185 181 133 17 751
Seung Ho Hong South Korea 17 236 0.9× 153 0.7× 242 1.3× 204 1.1× 204 1.5× 40 860
Leighton R. James United States 19 472 1.8× 130 0.6× 103 0.6× 120 0.7× 166 1.2× 38 961
C P Sung United States 8 288 1.1× 159 0.7× 111 0.6× 224 1.2× 63 0.5× 11 775
P. Salbach Germany 9 211 0.8× 122 0.6× 215 1.2× 195 1.1× 42 0.3× 15 811
Harry A.J. Struijker Boudier Netherlands 14 303 1.2× 170 0.8× 90 0.5× 435 2.4× 89 0.7× 27 967
Bertrand Toutain France 21 444 1.7× 330 1.5× 80 0.4× 178 1.0× 112 0.8× 42 951
Drew A. Sukovich United States 11 324 1.2× 109 0.5× 152 0.8× 170 0.9× 218 1.6× 14 928
Eddy S. Konaniah United States 13 273 1.0× 111 0.5× 166 0.9× 151 0.8× 115 0.9× 17 752
Yiu-Fai Chen United States 14 497 1.9× 134 0.6× 162 0.9× 463 2.6× 157 1.2× 17 1.1k
Meghan T. Walsh United States 14 365 1.4× 125 0.6× 192 1.0× 152 0.8× 146 1.1× 22 931

Countries citing papers authored by J C Monge

Since Specialization
Citations

This map shows the geographic impact of J C Monge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J C Monge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J C Monge more than expected).

Fields of papers citing papers by J C Monge

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J C Monge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J C Monge. The network helps show where J C Monge may publish in the future.

Co-authorship network of co-authors of J C Monge

This figure shows the co-authorship network connecting the top 25 collaborators of J C Monge. A scholar is included among the top collaborators of J C Monge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J C Monge. J C Monge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Černáček, Peter, Duncan J. Stewart, J C Monge, & Jean‐Lucien Rouleau. (2003). The endothelin system and its role in acute myocardial infarction. Canadian Journal of Physiology and Pharmacology. 81(6). 598–606. 43 indexed citations
2.
Campbell, Andrew, et al.. (1998). Direct DNA injection of vascular endothelial growth factor induces angiogenesis in non-ischemic myocardium. Journal of the American College of Cardiology. 31. 25–25. 2 indexed citations
3.
Monge, J C. (1998). Neurohormonal Markers of Clinical Outcome in Cardiovascular Disease: Is Endothelin the Best One?. Journal of Cardiovascular Pharmacology. 32. S36–S42. 25 indexed citations
4.
Babaei, Saeid, Krystyna Teichert-Kuliszewska, J C Monge, et al.. (1998). Role of Nitric Oxide in the Angiogenic Response In Vitro to Basic Fibroblast Growth Factor. Circulation Research. 82(9). 1007–1015. 173 indexed citations
5.
Cybulsky, Andrey V., J C Monge, J Papillon, & Alison J. McTavish. (1995). Complement C5b-9 activates cytosolic phospholipase A2 in glomerular epithelial cells. American Journal of Physiology-Renal Physiology. 269(5). F739–F749. 38 indexed citations
6.
Stewart, Duncan J., et al.. (1994). Role of cyclic nucleotides in the regulation of endothelin-1 production by human endothelial cells. American Journal of Physiology-Heart and Circulatory Physiology. 266(3). H944–H951. 16 indexed citations
7.
Baldo, Allain, Allan D. Sniderman, Rita Kohen Avramoglu, et al.. (1993). The adipsin-acylation stimulating protein system and regulation of intracellular triglyceride synthesis.. Journal of Clinical Investigation. 92(3). 1543–1547. 195 indexed citations
8.
Zhang, Zhongtao, Allan D. Sniderman, David Kalant, et al.. (1993). The role of amino acids in ApoB100 synthesis and catabolism in human HepG2 cells.. Journal of Biological Chemistry. 268(36). 26920–26926. 28 indexed citations
9.
Cianflone, Katherine, et al.. (1992). Pathogenesis of carbohydrate-induced hypertriglyceridemia using HepG2 cells as a model system.. Arteriosclerosis and Thrombosis A Journal of Vascular Biology. 12(3). 271–277. 52 indexed citations
10.
Fry, Edward T.A., David L. Mack, J C Monge, Joseph J. Billadello, & Burton E. Sobel. (1990). Labeling of human clots in vitro with an active-site mutant of t-PA.. PubMed. 31(2). 187–91. 7 indexed citations
11.
Monge, J C, et al.. (1989). Heparin and concanavalin A interaction as a model for studying the mechanism of the anticoagulant activity. Thrombosis Research. 54(3). 237–243. 4 indexed citations
12.
Monge, J C, Charles L. Lucore, Edward T.A. Fry, Burton E. Sobel, & Joseph J. Billadello. (1989). Characterization of Interaction of Active-site Serine Mutants of Tissue-type Plasminogen Activator with Plasminogen Activator Inhibitor-1. Journal of Biological Chemistry. 264(18). 10922–10925. 13 indexed citations
13.
Ross, Robert S., Richard E. Gregg, S W Law, et al.. (1988). Homozygous hypobetalipoproteinemia: a disease distinct from abetalipoproproteinemia at the molecular level.. Journal of Clinical Investigation. 81(2). 590–595. 38 indexed citations
14.
Rall, Christopher, J M Hoeg, Richard E. Gregg, et al.. (1988). Enhanced apolipoprotein E production with normal hepatic mRNA levels in the Watanabe heritable hyperlipidemic rabbit.. Arteriosclerosis An Official Journal of the American Heart Association Inc. 8(6). 804–809. 12 indexed citations
15.
Higuchi, Keiichi, J C Monge, S W Law, et al.. (1987). The human apoB-100 gene: ApoB-100 is encoded by a single copy gene in the human genome. Biochemical and Biophysical Research Communications. 144(3). 1332–1339. 17 indexed citations
16.
Lackner, Karl J., J C Monge, Richard E. Gregg, et al.. (1986). Analysis of the apolipoprotein B gene and messenger ribonucleic acid in abetalipoproteinemia.. Journal of Clinical Investigation. 78(6). 1707–1712. 63 indexed citations
17.
Law, S W, et al.. (1985). Human apoB-100 gene resides in the p23 → pter region of chromosome 2. Biochemical and Biophysical Research Communications. 131(2). 1003–1012. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026